Applied Therapeutics (APLT) Competitors $0.34 0.00 (-0.38%) Closing price 07/3/2025 03:50 PM EasternExtended Trading$0.34 0.00 (-0.30%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLT vs. DRUG, GNFT, FDMT, EPRX, YMAB, ALMS, ELDN, OGI, NLTX, and TILShould you be buying Applied Therapeutics stock or one of its competitors? The main competitors of Applied Therapeutics include Bright Minds Biosciences (DRUG), GENFIT (GNFT), 4D Molecular Therapeutics (FDMT), Eupraxia Pharmaceuticals (EPRX), Y-mAbs Therapeutics (YMAB), Alumis (ALMS), Eledon Pharmaceuticals (ELDN), Organigram Global (OGI), Neoleukin Therapeutics (NLTX), and Instil Bio (TIL). These companies are all part of the "pharmaceutical products" industry. Applied Therapeutics vs. Its Competitors Bright Minds Biosciences GENFIT 4D Molecular Therapeutics Eupraxia Pharmaceuticals Y-mAbs Therapeutics Alumis Eledon Pharmaceuticals Organigram Global Neoleukin Therapeutics Instil Bio Bright Minds Biosciences (NASDAQ:DRUG) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership. Do analysts prefer DRUG or APLT? Bright Minds Biosciences presently has a consensus target price of $83.25, suggesting a potential upside of 194.17%. Applied Therapeutics has a consensus target price of $6.10, suggesting a potential upside of 1,710.09%. Given Applied Therapeutics' higher possible upside, analysts clearly believe Applied Therapeutics is more favorable than Bright Minds Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bright Minds Biosciences 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Applied Therapeutics 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more risk and volatility, DRUG or APLT? Bright Minds Biosciences has a beta of -6.01, indicating that its stock price is 701% less volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500. Do institutionals & insiders hold more shares of DRUG or APLT? 40.5% of Bright Minds Biosciences shares are held by institutional investors. Comparatively, 98.3% of Applied Therapeutics shares are held by institutional investors. 42.7% of Bright Minds Biosciences shares are held by insiders. Comparatively, 1.6% of Applied Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, DRUG or APLT? Bright Minds Biosciences has higher earnings, but lower revenue than Applied Therapeutics. Bright Minds Biosciences is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright Minds BiosciencesN/AN/A-$2.06M-$0.36-78.61Applied Therapeutics$460K103.72-$105.62M-$0.43-0.78 Is DRUG or APLT more profitable? Bright Minds Biosciences' return on equity of -14.56% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Bright Minds BiosciencesN/A -14.56% -14.29% Applied Therapeutics N/A -184.67%-84.02% Does the media refer more to DRUG or APLT? In the previous week, Bright Minds Biosciences had 7 more articles in the media than Applied Therapeutics. MarketBeat recorded 8 mentions for Bright Minds Biosciences and 1 mentions for Applied Therapeutics. Bright Minds Biosciences' average media sentiment score of 0.04 beat Applied Therapeutics' score of 0.00 indicating that Bright Minds Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bright Minds Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Applied Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryBright Minds Biosciences beats Applied Therapeutics on 10 of the 15 factors compared between the two stocks. Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLT vs. The Competition Export to ExcelMetricApplied TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$45.30M$2.92B$5.56B$9.04BDividend YieldN/A2.44%5.22%3.99%P/E Ratio-0.7821.5627.6520.23Price / Sales103.72283.26419.56119.26Price / CashN/A41.7026.2128.59Price / Book0.697.538.035.65Net Income-$105.62M-$55.14M$3.18B$249.15M7 Day Performance8.33%4.22%2.88%2.91%1 Month Performance-8.72%0.91%1.67%4.11%1 Year Performance-92.53%5.40%34.39%20.98% Applied Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLTApplied Therapeutics3.7916 of 5 stars$0.34-0.4%$6.10+1,710.1%-92.5%$45.30M$460K-0.7830News CoverageGap UpDRUGBright Minds Biosciences2.8403 of 5 stars$28.08+0.3%$83.25+196.4%+2,595.0%$196.36MN/A-77.48N/ANews CoverageAnalyst ForecastAnalyst RevisionGNFTGENFIT1.9727 of 5 stars$3.87-0.6%$13.00+236.4%-8.2%$193.25M$76.77M0.00120Positive NewsFDMT4D Molecular Therapeutics2.27 of 5 stars$4.18-3.1%$29.56+607.7%-80.6%$192.73M$40K-1.31120EPRXEupraxia Pharmaceuticals2.4518 of 5 stars$5.35-0.7%$11.00+105.5%+117.3%$192.51MN/A-7.0429Gap UpYMABY-mAbs Therapeutics3.1314 of 5 stars$4.21-1.2%$15.60+270.7%-62.2%$190.86M$87.68M-6.59150News CoverageALMSAlumis2.8876 of 5 stars$3.45+5.3%$22.86+562.0%N/A$189.08MN/A0.00N/AELDNEledon Pharmaceuticals2.5486 of 5 stars$3.13+2.3%$9.00+187.5%+20.7%$187.42MN/A-1.4910OGIOrganigram Global0.528 of 5 stars$1.40+1.1%N/A-10.4%$186.85M$117.47M13.95860News CoverageNLTXNeoleukin TherapeuticsN/A$19.75+2.9%N/A-41.1%$185.61MN/A-6.3590High Trading VolumeTILInstil Bio2.6075 of 5 stars$27.72+16.4%$119.00+329.4%+185.4%$182.28MN/A-2.32410News CoverageHigh Trading Volume Related Companies and Tools Related Companies Bright Minds Biosciences Alternatives GENFIT Alternatives 4D Molecular Therapeutics Alternatives Eupraxia Pharmaceuticals Alternatives Y-mAbs Therapeutics Alternatives Alumis Alternatives Eledon Pharmaceuticals Alternatives Organigram Global Alternatives Neoleukin Therapeutics Alternatives Instil Bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLT) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
